跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
SEBITAR SOLUTION ( REFORMULATED ) - HSA Drug Approval Details
Approvals
/
HSA
/
SEBITAR SOLUTION ( REFORMULATED )
Approved
THERAPEUTIC
SEBITAR SOLUTION ( REFORMULATED )
EGO PHARMACEUTICALS PTY LTD (AUSTRALIA)
🇸🇬 Health Sciences Authority
Approval Date
Feb 26, 2008
Approval ID
f45ed822196997d8
Company
EGO PHARMACEUTICALS PTY LTD (AUSTRALIA)
Type
Therapeutic
Approval Details
Approval Id
f45ed822196997d8
Drug Name
SEBITAR SOLUTION ( REFORMULATED )
Product Name
SEBITAR SOLUTION ( REFORMULATED )
Approval Number
SIN13415P
Approval Date
2008-02-26
Registrant
EGO PHARMACEUTICALS (SINGAPORE) PTE. LTD.
Licence Holder
EGO PHARMACEUTICALS (SINGAPORE) PTE. LTD.
Drug Type
Therapeutic
Forensic Classification
GENERAL SALE LIST
Dosage Form
SOLUTION
Route Of Administration
TOPICAL
Pharma Manufacturer Name
EGO PHARMACEUTICALS (SINGAPORE) PTE. LTD.
Company Detail Path
/organization/ego-pharmaceuticals-singapore-pte-ltd
Active Ingredients
Tar
1.00 % w/w
Salicylic Acid
2.00% w/w
Coal Tar Solution
1.00 % w/w
COAL TAR SOLUTION
1% W/W
SALICYLIC ACID
2% W/W
TAR
1% W/W
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
Feb 26, 2008
Approval ID
f45ed822196997d8
Type
Therapeutic
Back to HSA Approvals